News
16h
Zacks Investment Research on MSNRoche's Q1 Sales Increase Y/Y on Solid Performance of Key DrugsSwiss pharma giant Roche Holding AG RHHBY posted strong growth in the first quarter of 2025. Sales increased 7% year over ...
18h
Zacks Investment Research on MSNEli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseThe market expects Eli Lilly (LLY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is ...
Eli Lilly (LLY) is scheduled to release its Q1 earnings on May 1, and analysts continue to stay positive, holding onto Buy ratings for the ...
Sarat Sethi says Zoetis stock is a better pick than Elanco for 2025. He explained his view in a recent interview with CNBC.
Johnson & Johnson has started 2025 better than I expected, even with the long-running talc saga. Find out why I remain ...
The Pennsylvania-based company said it expected a $20 million to $25 million hit from Trump's shifting trade policies. "We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results